“If I am here, it is because the system failed”: a critical qualitative study of global commercial clinical trials for advanced cancer in Chile
The conditions that make Chile an attractive hub for cancer commercial clinical trials are determined by an interplay of global, national, and community-level structural arrangements between public and private actors. Chile serves as an important global health case study on the role of the pharmaceutical industry in capitalizing on systemic healthcare failures to advance clinical research on metastatic cancer.
Authors
- Anne‐Emanuelle Birn (ORCID: https://orcid.org/0000-0002-0314-5913)
- Loreto Fernández‐González (ORCID: https://orcid.org/0000-0001-5026-6438)
- Amaya Perez‐Brumer (ORCID: https://orcid.org/0000-0003-2441-4358)
- Gary Rodin (ORCID: https://orcid.org/0000-0002-6626-6974)
- J Sapunar (ORCID: https://orcid.org/0000-0001-9908-8054)
Institutions
- Universidad de La Frontera (CL)
- Center for Global Development (US)
- University of Toronto (CA)
- Princess Margaret Cancer Centre (CA)
- Clínica Las Condes (CL)
- Public Health Ontario (CA)
Publication Details
- Journal
- Globalization and Health
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1186/s12992-025-01148-x
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00